Vaxart Inc (VXRT) Q3 2025 Earnings Call Highlights: Strategic Partnership and Revenue Surge ... [Yahoo! Finance]
Dynavax Technologies Corporation (DVAX)
Last dynavax technologies corporation earnings: 3/11 04:10 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.dynavax.com
Company Research
Source: Yahoo! Finance
For the complete transcript of the earnings call, please refer to the full earnings call transcript Positive Points Vaxart Inc ( VXRT ) announced a significant partnership with Dynavax, potentially worth up to $700 million, which validates the potential of their oral COVID-19 vaccine platform. The partnership with Dynavax includes an upfront license fee of $25 million and a $5 million equity investment, extending Vaxart's cash runway into the second quarter of 2027. Vaxart Inc ( VXRT ) reported a substantial increase in revenue for Q3 2025, reaching $72.4 million compared to $6.4 million in Q3 2024. The company presented positive phase 1 results for their second-generation norovirus vaccine, showing stronger antibody responses compared to the first generation. Vaxart Inc ( VXRT ) is on track to report multiple data sets from their COVID-19 phase 2B trial in 2026, which could further validate their oral vaccine platform. Negative Points Vaxart Inc ( VXRT ) received a s
Show less
Read more
Impact Snapshot
Event Time:
DVAX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DVAX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DVAX alerts
High impacting Dynavax Technologies Corporation news events
Weekly update
A roundup of the hottest topics
DVAX
News
- CDC vaccine panel set to debate hepatitis b shots, childhood immunizations [Seeking Alpha]Seeking Alpha
- Dynavax to Participate at the 8th Annual Evercore Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- Dynavax to Participate at the 8th Annual Evercore Healthcare ConferencePR Newswire
- Vaxart extends cash runway into Q2 2027 with Dynavax partnership and targets 2026 data readouts [Seeking Alpha]Seeking Alpha
- Vaxxas Appoints Veteran Vaccine Leader to Board as Company Advances Needle-Free Vaccine Patch Towards Market [Yahoo! Finance]Yahoo! Finance
DVAX
Earnings
- 11/5/25 - Beat
DVAX
Sec Filings
- 11/5/25 - Form 10-Q
- 11/5/25 - Form 8-K
- 10/16/25 - Form 8-K
- DVAX's page on the SEC website